Krsnaa Diagnostics Ltd

NSE: KRSNAA · BSE: 543328 · Healthcare · 50 announcements

Share price: ₹501.00
Market cap: ₹1,625 Cr
Revenue (annual): ₹772.8 Cr
Net profit (annual): ₹101.4 Cr
P/E (TTM): 16.6×Sector 54.5×
Promoter holding: 27.11%+0.00% QoQ
FII holding: 3.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

2 Nov 2026 15:06 IST BSE

Krsnaa Diagnostics Q2 FY27 Results: Net Profit ₹24.6 Cr, Up 2.9% YoY

Krsnaa Diagnostics Ltd reported revenue from operations of ₹271 Cr (+31.6% YoY) and net profit of ₹24.6 Cr (+2.9% YoY) for Q2 FY27.

Key figure: Net profit ₹24.6 Cr · +2.9% YoY

Open full results → Read the filing ↗

13 Aug 2026 23:21 IST BSE

Financial Results

Krsnaa Diagnostics Q1 FY27 Results: Net Profit ₹16.6 Cr, Down 19.0% YoY

Krsnaa Diagnostics Ltd reported revenue from operations of ₹235.5 Cr (+22.0% YoY) and net profit of ₹16.6 Cr (-19.0% YoY) for Q1 FY27.

Key figure: Net profit ₹16.6 Cr · -19.0% YoY

Open full results → Read the filing ↗

25 May 2026 20:12 IST BSE

Financial Results

Krsnaa Diagnostics Q4 FY26 Results: Net Profit ₹41.7 Cr, Up 101.4% YoY

Krsnaa Diagnostics Ltd reported revenue from operations of ₹192.6 Cr (+3.5% YoY) and net profit of ₹41.7 Cr (+101.4% YoY) for Q4 FY26.

Key figure: Net profit ₹41.7 Cr · +101.4% YoY

Open full results → Read the filing ↗

25 May 2026 20:11 IST BSE

Financial Results

Krsnaa Diagnostics Financial Results

Krsnaa Diagnostics approved FY2026 financial results and recommended a final dividend of ₹2 per share. The company reported consolidated annual profit of ₹101.43 Crore.

Value: ₹10.28 Cr

Open announcement → Read the filing ↗